What Medications Are Used to Treat ADHD?

ADHD is treated with two main categories of medication: stimulants and non-stimulants. Stimulants are the first-line treatment for most people and work for roughly 70 to 80 percent of those who try them. Non-stimulant options exist for people who don’t respond well to stimulants or can’t take them for medical reasons.

Stimulant Medications: The Two Families

All stimulant ADHD medications fall into one of two families: methylphenidate-based or amphetamine-based. Both work by boosting two chemical messengers in the brain, dopamine and norepinephrine, in the area responsible for attention, impulse control, and decision-making. Think of it this way: dopamine helps quiet background “noise” in the brain, while norepinephrine strengthens the important signals. The result is clearer thinking, better focus, and less impulsivity.

Amphetamine-based medications tend to be slightly stronger and longer-lasting than methylphenidate-based ones, but that doesn’t make them better for everyone. Many people respond well to one family and not the other, so finding the right fit often involves some trial and error.

Methylphenidate-Based Options

Ritalin is the oldest and most recognizable name in this group. It’s a short-acting tablet that lasts about 3 to 5 hours, which means it typically needs to be taken two or three times a day. For people who want longer coverage without multiple doses, several extended-release versions exist. Concerta lasts 8 to 12 hours using a special delivery system that releases medication gradually. Ritalin LA and Metadate CD use a bead-based capsule design to achieve a similar extended effect.

There are also formulations designed for people who have trouble swallowing pills. Quillivant XR is a long-acting liquid, Quillichew ER is a chewable tablet, and Daytrana is a skin patch that delivers methylphenidate through the arm. Focalin and Focalin XR are a slightly refined version of methylphenidate that some people tolerate better.

Amphetamine-Based Options

Adderall is the most widely known amphetamine medication. The immediate-release version lasts roughly 4 to 6 hours, while Adderall XR extends that to 8 to 12 hours. Dexedrine and Zenzedi are other short-acting amphetamine options, and Dexedrine Spansule provides an intermediate-acting version lasting 6 to 8 hours.

Vyvanse takes a different approach. It’s an amphetamine molecule bonded to an amino acid called lysine, which means your body has to break it down before the active ingredient kicks in. This creates a smoother onset and makes it harder to misuse. For people who can’t swallow capsules, Dynavel XR comes as a liquid and Adzenys XR-ODT dissolves on the tongue. In 2025, the FDA also approved Arynta, a new oral solution form of the same active ingredient in Vyvanse.

Non-Stimulant Medications

The FDA has approved four non-stimulant medications for ADHD: atomoxetine (Strattera), guanfacine (Intuniv), clonidine (Kapvay), and viloxazine (Qelbree). These are not controlled substances, which means prescriptions are simpler to manage and refill.

Atomoxetine works on norepinephrine and provides true 24-hour coverage. It takes several weeks to reach full effectiveness, unlike stimulants, which work within an hour or two of the first dose. This lag time can feel frustrating, but atomoxetine is a strong option for people who experience too much anxiety or jitteriness with stimulants.

Guanfacine and clonidine were originally developed as blood pressure medications. They work on a different brain pathway and are especially helpful for the hyperactivity and impulsivity side of ADHD. They’re frequently prescribed alongside a stimulant to fill in gaps that the stimulant doesn’t fully address, particularly in children.

Viloxazine (Qelbree) is the newest non-stimulant. It primarily affects norepinephrine and was approved for both children and adults. It’s become a useful alternative when atomoxetine doesn’t work well or causes unwanted side effects.

Short-Acting vs. Long-Acting Formulations

One of the most practical decisions in ADHD treatment is choosing between short-acting and long-acting medication. Short-acting versions (like Ritalin or Adderall immediate-release) last 3 to 6 hours. They offer flexibility: you can take a dose only when you need it, and the effects wear off quickly. The downside is that you may need to take pills multiple times a day, and there can be a noticeable “crash” as each dose fades.

Long-acting formulations (like Concerta, Adderall XR, or Vyvanse) last 8 to 12 hours and are designed to carry you through a full school or work day with a single morning dose. Most adults and school-age children start with a long-acting option for convenience. Some people add a small short-acting dose in the late afternoon if they need coverage into the evening.

Common Side Effects

Decreased appetite is the most frequent side effect of stimulant medications, affecting about 80 percent of people who take them. This is especially noticeable in children and often leads to weight loss or slower growth during the first year of treatment. Many families work around this by offering larger meals at breakfast and dinner when the medication’s effect on appetite is weakest.

Sleep difficulty is the other big one. Stimulants can make it harder to fall asleep and stay asleep, particularly if a long-acting dose is taken too late in the day. Stimulants can also cause a mild increase in heart rate and blood pressure. The change is usually small and not dangerous, but it matters for people with existing heart conditions.

Non-stimulants have their own side effect profiles. Atomoxetine can cause nausea, fatigue, and mood changes. Guanfacine and clonidine tend to cause drowsiness, especially in the first few weeks, which is why they’re sometimes given at bedtime.

Who Should Not Take Stimulants

Stimulant medications are classified as Schedule II controlled substances, the same category as opioid painkillers, because of their potential for misuse and addiction. When taken as prescribed for ADHD, the risk of addiction is low, but the classification means prescriptions typically can’t be called in by phone and may require monthly office visits for refills.

Certain medical conditions rule out stimulant use entirely. These include symptomatic heart disease, moderate to severe high blood pressure, advanced hardening of the arteries, structural heart abnormalities, and overactive thyroid. If you have any of these, non-stimulant medications or behavioral therapy are the safer path.

What to Expect During Treatment

Your prescriber will likely recommend monitoring your blood pressure and heart rate at each visit, regardless of which ADHD medication you take. For children, height and weight are tracked regularly to watch for growth effects. Dose adjustments are common in the first few months as you and your provider zero in on the right medication and amount.

Starting doses are deliberately low. Vyvanse, for example, typically begins at 30 mg per day with a ceiling of 70 mg. Concerta usually starts at 18 or 36 mg and can go up to 72 mg. Your prescriber will increase the dose gradually, checking in every few weeks, until symptoms improve without intolerable side effects. If the first medication doesn’t work, switching to the other stimulant family or trying a non-stimulant is a standard next step, not a sign that something is wrong.